EICHOR
● Active Not Recruiting
Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
Condition: Hematopoietic and Lymphatic System Neoplasm · Recurrent Ependymoma · Recurrent Ewing Sarcoma · Sponsor: National Cancer Institute (NCI)
About this study
This phase II pediatric MATCH treatment trial studies how well selpercatinib works in treating patients with solid tumors that may have spread from where they first started to nearby tissue, lymph nodes, or distant parts of the body (advanced), lymphomas, or histiocytic disorders that have activating RET gene alterations. Selpercatinib may block the growth of cancer cells that have specific genetic changes in an important signaling pathway (called the RET pathway) and may reduce tumor size.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (174)
| Children's Hospital of Alabama | Birmingham, Alabama, United States | — |
| Providence Alaska Medical Center | Anchorage, Alaska, United States | — |
| Banner Children's at Desert | Mesa, Arizona, United States | — |
| Phoenix Childrens Hospital | Phoenix, Arizona, United States | — |
| Banner University Medical Center - Tucson | Tucson, Arizona, United States | — |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | — |
| Kaiser Permanente Downey Medical Center | Downey, California, United States | — |
| City of Hope Comprehensive Cancer Center | Duarte, California, United States | — |
| Loma Linda University Medical Center | Loma Linda, California, United States | — |
| Miller Children's and Women's Hospital Long Beach | Long Beach, California, United States | — |
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
+ 162 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04320888